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Vogt-Koyanagi-Harada (VKH) disease is an autoimmune disease involving pigmented tissue in eyes, auditory system, skin, and 
central nervous system. The pathogenesis is a result of T cell lymphocyte reaction against melanocyte component, tyrosinase and 
tyrosinase-related protein. This disease uniquely affected pigmented race in Asia and native America, mostly women aged 20-50. We 
reported an 8-years-old boy complained for visual disturbance since 6 weeks prior admission. Two years earlier, the parents noted 
the patient eyes were looked red when photographed (suggesting a dilated pupil) preceded by whitened on the right forehead and 
nose and whitened hair, eyebrow and eyelashes. The examination showed a vitiligo and skin atrophy on right frontal and right nasal, 
poliosis on the eyebrows, eyelids and hair. The diameter of right pupil was 8 mm, with a paresis on 3rd, 4th, 6th, and 9th nerves. 
Fundus examination revealed sunset glow appearance. The visual acuity on the right eye: 2/60, left eye: 1-0. There’s positive serology 
for antitoxoplasma IgG, anti Rubella IgG, anti CMV IgG. The patient was diagnosed with a VKH disease and then prescribed with 
methylprednisolone 1 mg/kg/day. The patient also had further follow up with dermatovenerologist and ophthalmologist. The eye 
examination revealed an improvement on right eye panuveitis, with a remaining keratic precipitate in the endothelium, and minimal 
flare and cell on the anterior chamber. ENT consultation revealed no ear inflammation or hearing disturbance.
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INTRODUCTION
Vogt-Koyanagi-Harada (VKH) disease is a multisystem 
autoimmune disease that involves pigmented tissue in the eyes, 
auditory system, skin and central nervous system, without a 
history of penetrating trauma to the eyes. This disease mostly 
affected colored race, especially in Asia and America, frequently 
in women aged 20-50 years. It is rarely affected a child, but there 
was a reported case of a 4-year-old child with the disease. The 
exact cause of VKH disease is unknown, but there is a genetic 
predisposition. Patient with VKH disease usually presented 
with eye disorder which is a form of a bilateral granulomatous 
panuveitis. Ocular symptoms are often accompanied by 
extraocular organ involvement such as central nervous system, 
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auditory system and integumentary system or skin. Extraocular 
organ involvement can be a headache due to cerebrospinal fluid 
pleocytosis, dysacousia, poliosis, and vitiligo [1-6]. VKH disease 
was first described by Vogt in 1906, in patients who experienced 
poliosis accompanied by bilateral uveitis, vitiligo, alopecia, and 
dysacousia. Furthermore, Koyanagi also reported a similar case 
in 1929, while Harada in 1926, described a patient with uveitis, 
exudative retinal detachment and associated with the presence of 
pleocytosis in cerebrospinal fluid [1]. 
CASE REPORT
We report a boy 8 years and 9 months old, who visited Hasan 
Sadikin Hospital Bandung for a follow up visit, on April 1, 2010 with 
a chief complaint of blurred vision. The history taking obtained 
from the father informed us that the complaint began six weeks 
before examination without any previous eye trauma. It was 
accompanied with the patient’s hair and eyebrows looked partly 
white, and appearance of white patches on the right forehead and 
right nasal. Previously, the patient had been treated in Cicendo, 
Eye Hospital Bandung, and then he was referred to our pediatric 
department for further treatment. Patient is currently treated 
with methylprednisolone. Two years before, his father noticed the 
patient right’s eye was looked red when photographed, which 
was preceded by white patches on the right forehead. It then 
added with the hair, eyebrows and eyelashes become partly white 
and some white patches on the right nasal (Fig. 1). Patients came 
from families with low socioeconomic status. Physical examination 
revealed a good nutritional status, with vital signs was in the 
normal limit. There was vitiligo and atrophy in the right frontal and 
right nasal, poliosis on eyebrows, eyelashes, hair, and scoliosis (Figs. 
1 and 2). Neurological examination showed a round anisocoric 
pupil diameter, 3mm on ocular dextra and 8 mm on ocular sinistra, 
with light reflex - / + and the impression of paresis on the 3rd, 4th, 
6th, 9th cranial nerves (Figs. 2 and 3). Funduscopy examination, 
there was sunset glow appearance noted (Fig. 4). The visual acuity 
was right eye: 2/60, left eye: 1-0. Routine blood examination 
showed normal range with exception of elevated levels of total 
IgE: 1,570.4 IU/mL. Serology test performed with positive result for 
antitoxoplasma IgG, anti-Rubella IgG, anti-CMV IgG. Chest X-ray 
showed infiltrates suspected due to right pulmonary tuberculosis. 
Patient was diagnosed with Vogt-Koyanagi-Harada disease and 
then prescribed with methylprednisolone 1 mg/kg/day in three 
divided dose. This patient was also consulted to dermatology 
department and was prescribed with mometason furoate topical 
cream once daily. From the follow up control to ophthalmologist, 
the eye examination revealed an improvement on right eye 
panuveitis, with a remaining keratic precipitate in the endothelium, 
and minimal flare and cell on the anterior chamber. The patient still 
needed to continue his previous medication of homatropine eye 
drops three times daily and flumetholone eye drops every 4 h. ENT 
consultation revealed no ear inflammation or hearing disturbance.





Fig. 2. (A) Showed vitiligo on right forehead and right nasal (black 
arrows); (B) assymetrical uvula indicated paresis on nervus IX.  
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We will discuss the problem of establishing the diagnosis, 
follow-up, procedure and prognosis of this patient. VKH disease 
occurs in this patient is a rare case, since most cases affect women 
in the third-fourth decade. In Indonesia, VKH disease has been 
known primarily among ophthalmologist, but not been widely 
known by other doctors. For that particular reason that this case 
report is intended for us as pediatrician to be able to recognize this 
disease in early stage and provide appropriate treatment so the 
patient will have a better prognosis.
The etiology of VKH disease is not certain, but several studies 
suspected an autoimmune role of T lymphocytes against 
melanocytes cells which triggered by certain factors. Prodormal 
symptoms indicate the possibility of herpes family infections 
(Epstein-Barr virus, Cytomegalovirus) as a triggering factor. 
Histopathological findings as well as in vitro experiments 
and animal models reinforce the importance of the CD4+ T 
lymphocytes in the disease pathogenesis. The main target of this 
disease is antigens derived from melanocytes which are tyrosinase 
and tyrosinase-related protein. Both enzymes are involved in the 
formation of melanin and are specifically located on melanocytes 
cells [1, 5]. VKH disease occurs in genetically susceptible individuals. 
This is apparently because some types of human leukocyte 
antigen (HLA) was reported to be associated with the reported 
incidence of this disease [7]. HLA-DRB1 * 0405 has a relationship 
with approximately 90% of patients with VKH disease in Asia and 
in other countries. From a study concluded that VKH disease was 
a disease with a combined allelic predisposition with HLA alleles 
DQA1 * 0301 as the primary and HLA-DRB1 * 0405 allele as an 
additional cause of this disease. Also found that HLA DQB1 * 0604 
likely to have protective effects in this disease [7-10].
VKH disease has four clinical stages, prodormal, uveitic, 
convalescence, and chronic or recurrent. Extraocular 
manifestations usually occur in prodormal stage, convalecens 
stage, and chronic stage. Prodormal stage is characterized by 
presence of fever, nausea, and headache that lasts for 3-5 days. 
Nonspecific symptoms such as fever, and nausea also appear on 
the prodormal stadium. The auditory system involvement causing 
few symptoms such as dysacousia, tinnitus, high-frequency 
hearing disorders, and vertigo. While the involvement of the 
central nervous system, among others, would cause symptoms 
such as headache, meningismus, and pleocytosis that precede the 
ocular symptoms of 1-2 weeks. Although rare, focal neurological 
symptoms can occur such as paralysis of cranial nerves, and optic 
neuritis. Resemble symptoms of encephalitis can be found among 
others the existence of aphasia, personality disorders, decrease of 
consciousness, and seizure [1, 2, 6]. 
On uveitic stage, there will be the emergence of symptoms 
of photophobia, blurred vision and the presence of ocular pain. 
During examination we may find granulomatous bilateral anterior 
uveitis, with the precipitate of fat (mutton fat precipitates keratic) 
and nodules on the iris. We may also find choroiditis associated 
with the existence of exudative diffuse retinal detachment and 
hiperemic discus opticus. Cilliary body swelling can cause the 
diaphragm of lens-iris shifted anteriorly, causing narrowing of 
camera oculi anterior, and angle which results in an acute increase 
of intraocular pressure [1, 2, 6]. 
During convalescence stage, if patients receive proper treatment, 
eye symptoms and exudative diffuse retinal detachment will 
subside gradually. At this stage the fundus examination will reveal 
the form of ‘sunset glow’ (the fundus red-orange), with multiple 
depigmentation lesions of the retinal epithelium which scattered 
on the mid-peripheral fundus and a migration of retinal pigment 
epithelium. These indicate a severe aggression of melanocytes and 
pigmented tissue. On this stage we may find Sugiura sign, which 
is a depigmented limbus. Depigmentation can also be found on 
the skin such as vitiligo on the hands, shoulders, chest, back, face, 
Fig. 3. Paresis of 3rd, 4th, 6th cranial nerves.




poliosis (some part of hair, eyebrow, or eyelashes become white) 
and alopecia [1, 2, 6].
In the later stage, a chronic or recurrent uveitis may occur in 
17-73% of patients. This recurrence usually presents in the form 
of anterior uveitis, but also reported in posterior chamber which 
signifies an ongoing aggression against the melanocytes. At this 
stage complications can occur in the eyes such as glaucoma, 
cataracts, choroidal neovascular membranes, and gliosis in the 
retina and choroid. In the event of complications, there will posible 
disturbance in the visual acuity [1, 6]. 
Uveitis in VKH disease occurs bilaterally, but in this patient we 
found only a chronic residual symptom of uveitis which only 
appears in the right eye. It is still possible due to damage to the 
cilliary body may not occur in both eyes so that the residual 
symptoms only appear in one eye. This was also reported by 
Kouda, 2002 and Usui, 2009 on their patients. These patients had 
unilateral uveitis which developed into bilateral uveitis, only three 
patients continued to show the character of unilateral VKH disease 
[11, 12].
This patient has reached the chronic stage of the disease 
because the patient has had disturbances of visual acuity 
accompanied with vitiligo and poliosis (Fig. 1). On further 
examination, we also found cranial nerve paralysis (Figs. 2 and 
3) and the sunset glow on funduscopy examination (Fig. 4). It is 
presumed that two years prior when his father noted a red eye, 
the patients had symptoms of mydriasis in the right eye due to 
paralysis of the muscles in the cilliary body caused by previous 
uveitis. In this case, the patient was already in a chronic stage.
In 1980, the American Uveitis Society (Table 1) proposed 
diagnostic criteria by using the criteria proposed by Sugiura. 
However, these diagnostic criteria came short as it could not 
diagnose VKH disease in its early stage. So then, the International 
Committee on Nomenclature in 2001 proposed revisions to the 
diagnostic criteria for VKH disease, which divides patients into three 
categories: probable, incomplete and complete (Table 2) [1, 13-15]. 
VKH disease diagnosed based on clinical symptoms. In these 
patients the diagnosis is established using the criteria of the 
International Committee on Nomenclature who meet symptoms 
1 − 3 and 4 + 5 so this is a complete VKH disease. Diagnosis of 
pulmonary tuberculosis in these patients also cannot be enforced, 
although tuberculin skin test and chest radiograph was performed, 
according to the tuberculosis scoring system only meet two 
criteria with a total score of 2. Anergy reactions in patients with 
autoimmune diseases is due to an increase in Th2 lymphocytes 
function and suppression of lymphocyte function of Th1 cells that 
play a role in the formation of a positive reaction on tuberculin skin 
test.
Suspicion of scoliosis (Fig. 5) excluded by tests carried out 
by colleagues from the orthopedic department. Orthopedic 
anthropometric measurements was within normal limits, therefore 
the asymmetry of the trunk is a normal variation arising from the 
habit of asymmetrical sitting.
Further investigations directed more to assess the existing eye 
disorders. We can perform ultrasonography, which will describe 
a reflective thickening of the choroid which is mild and diffuse, 
with the existence of a localized exudative retinal detachment. 
This distinguishes VKH disease with idiopathic effusion uvea 
and metastasis from carcinoma showing high reflectivity [1]. 
Investigation of fluorescein angiography on the acute phase will 
show choroiditis lession as a multiple hyperfluorescein dots that 
will unite to form an exudative retinal detachment. Shinzato, et 
al. [16] showed that the examination of anti Ro / SS-A showed a 
positive reaction in 10% of patients with VKH.
In this patient we found an increased total IgE levels, with 
differential count did not reveals any eosinophilia. This can 
lead to the existence of a hyper-IgE syndrome, but there is not 
enough data to support hyper-IgE syndrome diagnosis which 
one of them achieve total IgE levels above 2,000 IU/mL. So in 
this case, we should monitor the total IgE levels and clinical signs 
towards hyper-IgE syndrome [17, 18]. The serology test for CMV, 
Toxoplasma, Herpes and Rubella was conducted to find the trigger 
factors of VKH disease, and as a differential diagnosis the cause 
Table 1. Vogt-Koyanagi-Harada diagnostic criteria, the American Uveitis Society
No history of trauma or surgery and one finding from at least three of the following four groups: 
1.  Bilateral chronic iridocyclitis
2.    Posterior uveitis: exudative retinal detachment, formed fruste of retinal detachment (disc hyperemia or edema, subretinal macular edema) and 
‘sunset glow’ fundus   
3.  Neurological signs: tinnitus, meningismus, cranial nerve or central nervous system problem, cerebrospinal pleocytosis. 
4.  Cutaneous signs: alopecia, poliosis, vitiligo 
Adapted from. Source: de Carvalho JF, Yamamoto JH [1].apallergy.org




of uveitis. The results revealed the patient had the possibility of 
prior Rubella, CMV and Toxoplasma infection. Standard treatment 
for VKH disease is high dose systemic corticosteroids, and topical 
corticosteroids to treat anterior uveitis. Predisone can be used in 
an appropriate dose of 1-2 mg/kg/day peroral, with starting dose is 
1 to 1.2 mg/kg/day. There is no evidence that indicates intravenous 
delivery is better than the peroral administration. Some centers 
are using of intravenous methylprednisolone. Steroid is given for 
6-9 months prior to tappering off. This will give a better prognosis, 
decrease the duration of illness, decrease the incidence of 
convalescents stage, and decrease the extraocular manifestations 
[1]. Tappering off done by lowering the dose of prednisone 10 
mg/day weekly until the dose reached 40 mg/day, followed by 
reduced 5 mg/day dose weekly to 20 mg/day, then 2.5 mg/day 
weekly until the dose reached 10 mg/day. Next tappering off 
done by lowering the dose of 2.5 mg/day per month. Therapy was 
performed at least as long as six months [13, 19]. Corticosteroids 
administration can be done in a longer time in a state of chronic 
uveitis in the anterior segment, up to 48 months [20].
In refractory cases, steroid administration should be discontinued 
Table 2. Revised diagnostic criteria for disease Vogt-Koyanagi-Harada (VKH)
1. No history of penetrating ocular trauma  
2. No evidence of other ocular or systemic diseases 
3. Bilateral ocular disease; either a or b: 
    a. Early manifestations: 
        i. Diffuse choroiditis manifested as either: 
            1. Focal areas of subretinal fluid or 
            2. Bulous serous retinal detachment  
          ii. If equivocal fundus findings, then both of below: 
            1. Fluorescence angiography showing focal delayed choroidal perfusion, pinpoint leakage,  
                pooling within subretinal fluid, and optic nerve staining 
            2. Ultrasound showing diffuse choroidal thickening without posterior scleritis 
     b. Late manifestations 
          i. History suggestive of above, and both ii and iii or multiple from iii 
          ii. Ocular depigmentation 
             1. 'Sunset glow' Fundus 
             2. Sugiura sign 
          iii. Other ocular signs: 
              1. Nummular chorioretinal depigmented scar 
              2. RPE (Retinal pigment epithelium) clumping or 
              3. Recurrent or chronic anterior uveitis  
4. Neurological or auditory: 
    a. Meningismus 
    b. Tinnitus 
    c. Pleocytosis in cerebrospinal fluid 
5. Skin symptoms: 
    a. Alopecia 
    b. Poliosis 
    c. Vitiligo
Complete VKH: shows all the symptoms 1-5. Incomplete VKH: show symptoms 1-3 plus 4 or 5. Probable VKH: only show symptoms 1-3. Adapted from. 
Source: Read RW [6].
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immediately and replace it with other immunosuppressive 
drugs, such as cyclosporin (the most widely used after a 
steroid), cyclophosphamide, chlorambucil, azathioprine and 
mycophenolate mofetil. Cyclosporin dose is 3-5 mg/kg/day, 
whereas chlorambucil 0.1 mg/kg/day. We also must consider the 
side effects of these drugs which include the decrease amount 
of leukocytes, impaired kidney function and liver function [13]. 
Choroidal neovascular membranes can be treated with traditional 
photocoagulation or by using anti-angiogenic drugs. Closed angle 
glaucoma in the acute phase of VKH disease would improve after 
steroid administration steroid [1]. 
In this patients steroid treatment was given 1 mg/kg/day in 
three divided dose equal to 24 mg of methylprednisolone per day 
(methylprednisolone tablets 3 × 8 mg). We had to evaluate this 
therapy every two weeks to see any recurrence. The patient also 
needed evaluation from ophthalmologist and dermatologist. For 
further diagnosis, we planned for the patient to be consulted with 
ENT specialist to find whether there is a hearing disorder.
With administration of steroid drugs, two thirds of patients 
becomes able to maintain good visual acuity, with at least have a 
visual acuity of 20/40 or better, only a minority of patients (11%) 
having poor visual acuity (20/200 or better visual acuity). Treatment 
with corticosteroids can also control symptoms in almost all 
patients with uveitis. Patients will have a better prognosis if they 
have a good visual acuity at 1 month after onset, younger age at 
onset of disease, early treatment with corticosteroids [13, 19]. 
 With early diagnosis and appropriate treatment, this disease 
is not expected to develop into chronic or recurrence stage. No 
mortality associated with VKH disease has been reported, thus 
the life prognosis is good. With the current treatment, patients 
expected to have a better prognosis, especially the visual acuity. 
But unfortunately this patient came in an advanced stage, with 
already decrease in the visual acuity. Thus, the functional prognosis 
in this patient was bad. 
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